Zarina Agnese, Tolmane Ieva, Kreile Madara, Chernushenko Aleksandrs, Cernevska Gunta, Pukite Ieva, Micule Ieva, Krumina Zita, Krumina Astrida, Rozentale Baiba, Piekuse Linda
Scientific Laboratory of Molecular GeneticsRīga Stradiņš UniversityRigaLatvia.
Riga East Clinical University Hospitalstationary "Latvian Centre of Infectious Diseases"RigaLatvia.
Mol Genet Genomic Med. 2017 Jun 7;5(4):405-409. doi: 10.1002/mgg3.297. eCollection 2017 Jul.
Wilson disease (WD) is an autosomal recessive disorder of copper metabolism caused by allelic variants in gene. More than 500 distinct variants have been reported, the most common WD causing allelic variant in the patients from Central, Eastern, and Northern Europe is H1069Q.
All Latvian patients with clinically confirmed WD were screened for the most common mutation p.H1069Q by PCR Bi-PASA method. Direct DNA sequencing of gene (all 21 exons) was performed for the patients with WD symptoms, being either heterozygous for H1069Q or without it on any allele.
We identified 15 different allelic variants along with eight non-disease-causing allelic variants. Based on the gene molecular analysis and patients' clinical data variant p.His1069Gln was found in 66.9% of WD alleles. Wide clinical variability was observed among individuals with the same genotype. The results of our study confirm that neurological manifestations of WD are typically present later than the liver disease but no significant association between the presence/absence of the most common genetic variant and mode of initial WD presentation or age at presentation was identified.
(1) The most prevalent mutation in Latvian patients with Wilson disease was c.3207C>A (p.His1069Gln); (2) No significant phenotype-genotype correlation was found in Latvian patients with Wilson disease; (3) The estimated prevalence of Wilson disease in Latvia is 1 of 24,000 cases which is higher than frequently quoted prevalence of 1: 30,000.
威尔逊病(WD)是一种由基因等位变异引起的常染色体隐性铜代谢紊乱疾病。已报道了500多种不同的变异,在中欧、东欧和北欧患者中最常见的导致WD的等位变异是H1069Q。
采用PCR双引物扩增特异性等位基因分析(Bi-PASA)方法,对所有临床确诊的拉脱维亚WD患者进行最常见突变p.H1069Q的筛查。对有WD症状的患者进行基因(所有21个外显子)直接DNA测序,这些患者要么是H1069Q杂合子,要么任何等位基因上都没有该突变。
我们鉴定出15种不同的等位变异以及8种非致病等位变异。基于基因分子分析和患者临床数据,发现p.His1069Gln变异存在于66.9%的WD等位基因中。在具有相同基因型的个体中观察到广泛的临床变异性。我们的研究结果证实,WD的神经学表现通常比肝脏疾病出现得晚,但未发现最常见基因变异的有无与WD初始表现方式或发病年龄之间存在显著关联。
(1)拉脱维亚威尔逊病患者中最常见的突变是c.3207C>A(p.His1069Gln);(2)拉脱维亚威尔逊病患者中未发现显著的表型-基因型相关性;(3)拉脱维亚威尔逊病的估计患病率为1/24000例,高于经常引用的1:30000的患病率。